Literature DB >> 15883875

Cytokine response of lymphocytes persistently infected with Chlamydia pneumoniae.

Riho Takano1, Hiroyuki Yamaguchi, Shigehiro Sugimoto, Shinichi Nakamura, Herman Friedman, Yoshimasa Yamamoto.   

Abstract

Chlamydia pneumoniae infection of lymphocytes in blood has been documented, and it is apparent that control of this pathogen in lymphocytes as well as immune functions of the infected lymphocytes may be critical in the development of chronic inflammatory diseases associated with infection by this bacterium. Since immune function of lymphocytes infected with C. pneumoniae has not been well studied, the cytokine response of lymphocytes infected with this pathogen was analyzed using an in vitro infection model of the Molt-4 human lymphoid cell line. C. pneumoniae infection of the cells showed a persistent infection without any vigorous growth of the bacteria. Analysis of the cytokine response of the cells persistently infected with C. pneumoniae showed minimum induction of inflammatory cytokine TNF-alpha message, determined by real-time reverse transcription (RT)-PCR in the lymphocytes, even though the infection of THP-1 monocytic cells showed a marked induction of this cytokine messages. BIC (a lymphocyte activation marker gene) as well as IFN-gamma messages were also minimally induced by the infection in Molt-4 lymphocytes. In contrast, constitutive expression of interleukin 8 (IL-8) messages of Molt-4 cells was suppressed by the infection. Thus, these results suggest that lymphocytes persistently infected with C. pneumoniae may have attenuated cytokine responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883875     DOI: 10.1007/s00284-004-4416-2

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  41 in total

1.  Analysis of Chlamydia pneumoniae growth in cells by reverse transcription-PCR targeted to bacterial gene transcripts.

Authors:  Shusaku Haranaga; Hideaki Ikejima; Hiroyuki Yamaguchi; Herman Friedman; Yoshimasa Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

Review 2.  Control of mRNA processing and decay in prokaryotes.

Authors:  P Alifano; C B Bruni; M S Carlomagno
Journal:  Genetica       Date:  1994       Impact factor: 1.082

3.  Chlamydia pneumoniae and atherosclerosis.

Authors:  J T Grayston
Journal:  Rev Med Interne       Date:  1996       Impact factor: 0.728

4.  Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae.

Authors:  M E Rottenberg; A Gigliotti Rothfuchs; D Gigliotti; M Ceausu; C Une; V Levitsky; H Wigzell
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

5.  Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma.

Authors:  D L Hahn; R W Dodge; R Golubjatnikov
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

6.  In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells.

Authors:  T C Quinn; C A Gaydos
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

7.  Chlamydia pneumoniae as a cause of reactive arthritis.

Authors:  R Saario; A Toivanen
Journal:  Br J Rheumatol       Date:  1993-12

Review 8.  Chemokines and atherosclerosis.

Authors:  T J Reape; P H Groot
Journal:  Atherosclerosis       Date:  1999-12       Impact factor: 5.162

9.  Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes.

Authors:  M Berger; B Schröder; G Daeschlein; W Schneider; A Busjahn; I Buchwalow; F C Luft; H Haller
Journal:  J Lab Clin Med       Date:  2000-09

10.  Detection of activated T lymphocytes in the human atherosclerotic plaque.

Authors:  G K Hansson; J Holm; L Jonasson
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

View more
  4 in total

1.  Development of diabetes in non-obese diabetic mice promotes Chlamydia pneumoniae dissemination from lung to peripheral blood.

Authors:  Hiroyuki Yamaguchi; Ichiro Oshio; Takako Osaki; Satoru Kurata; Yoshimasa Yamamoto; Shigeru Kamiya
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

2.  Chlamydia pneumoniae and osteoporosis-associated bone loss: a new risk factor?

Authors:  M Di Pietro; G Schiavoni; V Sessa; F Pallotta; G Costanzo; R Sessa
Journal:  Osteoporos Int       Date:  2012-11-16       Impact factor: 4.507

3.  Treating reactive arthritis: insights for the clinician.

Authors:  John D Carter
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-02       Impact factor: 5.346

4.  Chlamydia pneumoniae inhibits activated human T lymphocyte proliferation by the induction of apoptotic and pyroptotic pathways.

Authors:  Norma Olivares-Zavaleta; Aaron Carmody; Ronald Messer; William M Whitmire; Harlan D Caldwell
Journal:  J Immunol       Date:  2011-05-04       Impact factor: 5.422

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.